| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GCC.1178 |
| P698 | PubMed publication ID | 11550284 |
| P2093 | author name string | C Hoffmann | |
| T Ozaki | |||
| K L Schaefer | |||
| W Winkelmann | |||
| B Dockhorn-Dworniczak | |||
| C Poremba | |||
| H Juergens | |||
| S Ahrens | |||
| M Paulussen | |||
| W Boecker | |||
| A Hillmann | |||
| C Brinkschmidt | |||
| D Wai | |||
| J Rerin | |||
| P2860 | cites work | DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma | Q74649716 |
| Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways | Q77976506 | ||
| Cytogenetic aberrations in Ewing sarcoma: are secondary changes associated with clinical outcome? | Q78018572 | ||
| EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results | Q78205464 | ||
| The 5' region of the COX4 gene contains a novel overlapping gene, NOC4 | Q22010070 | ||
| Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours | Q24298221 | ||
| A new member of the ETS family fused to EWS in Ewing tumors | Q24317176 | ||
| The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 | Q24629399 | ||
| EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma | Q27851507 | ||
| Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12) | Q28291773 | ||
| Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast | Q30883731 | ||
| Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis | Q35754634 | ||
| Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma | Q35809865 | ||
| Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization | Q36421638 | ||
| Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis | Q36617437 | ||
| Demonstration of the translocation der(16)t(1;16)(q12;q11.2) in interphase nuclei of Ewing tumors | Q38506119 | ||
| Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors | Q39370472 | ||
| Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas | Q42859308 | ||
| Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the | Q43201271 | ||
| Loss of chromosome 16q in lobular carcinoma in situ | Q46668779 | ||
| Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa | Q46754150 | ||
| Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? | Q50752435 | ||
| Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents | Q52870795 | ||
| EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma | Q54158232 | ||
| Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas. | Q55474980 | ||
| Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis | Q57252309 | ||
| Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer | Q57426147 | ||
| The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts | Q57756648 | ||
| Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy | Q64382940 | ||
| Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16) | Q67920396 | ||
| A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor | Q68467794 | ||
| Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80 | Q70911486 | ||
| Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization | Q71598960 | ||
| Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors | Q73094960 | ||
| Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas | Q73114191 | ||
| Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma | Q73501765 | ||
| 16q loss of heterozygosity and microsatellite instability in Wilms' tumor | Q73937460 | ||
| Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization | Q74223875 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 164-171 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
| P1476 | title | Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors | |
| P478 | volume | 32 |
| Q39493814 | 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma |
| Q51352355 | A t(17;22)(q21;q12) with partial ETV4 deletion in a soft tissue Ewing sarcoma |
| Q21198840 | An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma |
| Q53520709 | Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q36907188 | Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group. |
| Q38484958 | Chromosomal alterations in osteosarcoma cell lines revealed by comparative genomic hybridization and multicolor karyotyping |
| Q38003799 | Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas |
| Q37078506 | Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors |
| Q34700651 | Copy Number Alterations and Methylation in Ewing's Sarcoma |
| Q36585123 | Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies |
| Q28085071 | Diagnosis and treatment of Ewing sarcoma of the bone: a review article |
| Q38101501 | Ependymoma in children: molecular considerations and therapeutic insights. |
| Q37981253 | Ewing Sarcoma: Biology-Based Therapeutic Perspectives |
| Q37980482 | Ewing Sarcoma: Clinical State-of-the-Art |
| Q34028538 | Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone |
| Q78434015 | Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas |
| Q35748208 | Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups |
| Q34691553 | Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations |
| Q37845833 | High-dose chemotherapy and stem cell rescue for high-risk Ewing’s family of tumors |
| Q28244685 | In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type |
| Q80387809 | Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression |
| Q35183100 | Molecular genetics of pediatric soft tissue tumors: clinical application |
| Q37200438 | Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma |
| Q39823354 | Pathobiologic Markers of the Ewing Sarcoma Family of Tumors: State of the Art and Prediction of Behaviour |
| Q53567961 | Phyllodes tumors of the breast segregate in two groups according to genetic criteria |
| Q52852427 | Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group |
| Q36562720 | Recent advances in the molecular pathogenesis of Ewing's sarcoma |
| Q26801785 | Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes |
| Q41303735 | Targeting the p53 Pathway in Ewing Sarcoma. |
| Q41865440 | The clone wars - revenge of the metastatic rogue state: the sarcoma paradigm. |
| Q38209599 | Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene? |
| Q26782649 | Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward? |
Search more.